Current Approach to Hepatocellular Carcinoma

Surgical Clinics of North America

Volumn 90, Issue 4, 2010, Pages 803-816

  Abrams, Peter ^a   Marsh, J Wallis ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Locoregional therapy; Partial hepatectomy; Radiofrequency ablation; Transarterial chemoembolization

Indexed keywords

TOXIN;

AGE DISTRIBUTION; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER THERAPY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; GEOGRAPHIC DISTRIBUTION; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; PARTIAL HEPATECTOMY; PERCUTANEOUS ETHANOL INJECTION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SEX DIFFERENCE; TRANSARTERIAL CHEMOEMBOLIZATION; TRANSARTERIAL RADIOEMBOLIZATION; TREATMENT INDICATION; BIOPSY; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION; DIAGNOSTIC IMAGING; LIVER NEOPLASMS; LIVER RESECTION; PROCEDURES; PROGNOSIS;

BIOPSY; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; DIAGNOSTIC IMAGING; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PROGNOSIS;

EID: 77954654244     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2010.04.010     Document Type: Review

References (70)

1. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol 2001, 2(9):533-543.
2. El-Serag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999, 340:745-750.
3. El-Serag H.B., Davila J.A., Petersen N.J., et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003, 139(10):817-823.
4. El-Serag H.B. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004, 127(5 Suppl 1):S27-S34.
5. Okuda K. Epidemiology of primary liver cancer. Primary liver cancer in Japan 1992, 3-15. Springer-Verlag, Tokyo. T. Tobe (Ed.).
6. Dumortier J., Lombard-Bohas C., Valette P.J., et al. Needle tract recurrence of hepatocellular carcinoma after liver transplantation. Gut 2000, 47(2):301.
7. Huffman GR, Uzar A, Gorgulu S, et al. Preoperative needle biopsy and long-term outcome of patients undergoing resection for hepatocellular carcinoma. Presented at the 48th Annual Meeting of the American Association for the Study of Liver Diseases. Chicago (IL), November 7-11, 1997.
8. Molmenti E.P., Klintmalm G.B. Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry. Liver Transpl 2002, 8(9):736-748.
9. Barbara L., Benzi G., Gaiani S., et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992, 16(1):132-137.
10. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334(11):693-699.
11. Iwasaki M., Furuse J., Yoshino M., et al. Sonographic appearances of small hepatic nodules without tumor stain on contrast-enhanced computed tomography and angiography. J Clin Ultrasound 1998, 26(6):303-307.
12. Fracanzani A.L., Burdick L., Borzio M., et al. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology 2001, 34(6):1109-1112.
13. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42(5):1208-1236.
14. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001, 35(3):421-430.
15. Torzilli G., Minagawa M., Takayama T., et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999, 30(4):889-893.
16. Levy I., Greig P.D., Gallinger S., et al. Resection of hepatocellular carcinoma without preoperative tumor biopsy. Ann Surg 2001, 234(2):206-209.
17. Mueller G.C., Hussain H.K., Carlos R.C., et al. Effectiveness of MR imaging in characterizing small hepatic lesions: routine versus expert interpretation. AJR Am J Roentgenol 2003, 180(3):673-680.
18. Shimizu A., Ito K., Koike S., et al. Cirrhosis or chronic hepatitis: evaluation of small (
19. Marsh J.W., Dvorchik I., Subotin M., et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 1997, 26(2):444-450.
20. Marsh J.W., Dvorchik I., Bonham C.A., et al. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?. Cancer 2000, 88(3):538-543.
21. American Liver Tumor Study Group. A randomized prospective multi-institutional trial of orthotopic liver transplantation or partial hepatic resection with or without adjuvant chemotherapy for hepatocellular carcinoma. Investigators Booklet and Protocol. Richmond (VA): United Network for Organ Sharing; 1998.
22. Fong Y., Sun R.L., Jarnagin W., et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999, 229(6):790-799.
23. Grazi G.L., Ercolani G., Pierangeli F., et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 2001, 234(1):71-78.
24. Bruix J., Castells A., Bosch J., et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996, 111(4):1018-1022.
25. Llovet J.M., Fuster J., Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999, 30(6):1434-1440.
26. Nguyen K.T., Gamblin T.C., Geller D.A. World review of laparoscopic liver resection-2,804 patients. Ann Surg 2009, 250(5):831-841.
27. Okada S., Shimada K., Yamamoto J., et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994, 106(6):1618-1624.
28. Ercolani G., Grazi G.L., Ravaioli M., et al. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg 2003, 237(4):536-543.
29. Adachi E., Maeda T., Matsumata T., et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995, 108(3):768-775.
30. Morimoto O., Nagano H., Sakon M., et al. Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas. J Hepatol 2003, 39(2):215-221.
31. Imamura H., Matsuyama Y., Tanaka E., et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003, 38(2):200-207.
32. Schwartz J.D., Schwartz M., Mandeli J., et al. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol 2002, 3(10):593-603.
33. Poon R.T., Fan S.T., Lo C.M., et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002, 235(3):373-382.
34. Johnson P.J., Williams R. Cirrhosis and the aetiology of hepatocellular carcinoma. J Hepatol 1987, 4(1):140-147.
35. Okuda K. Hepatocellular carcinoma. J Hepatol 2000, 32(Suppl 1):225-237.
36. Iwatsuki S., Gordon R.D., Shaw B.W., et al. Role of liver transplantation in cancer therapy. Ann Surg 1985, 202(4):401-407.
37. Macdougal B.R.D., Williams R. Indications and assessment for orthotopic liver transplantation. Liver transplantation 1983, 59. Grune & Stratton, London. R.Y. Calne (Ed.).
38. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991, 110(4):726-734.
39. Bismuth H., Chiche L., Adam R., et al. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993, 218(2):145-151.
40. Romani F., Belli L.S., Rondinara G.F., et al. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver. J Am Coll Surg 1994, 178(4):379-384.
41. Sotiropoulos G.C., Druhe N., Sgourakis G., et al. Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach?. Dig Dis Sci 2009, 54(10):2264-2273.
42. Freeman R.B., Wiesner R.H., Edwards E., et al. Results of the first year of the new liver allocation plan. Liver Transpl 2004, 10(1):7-15.
43. Sharma P., Balan V., Hernandez J.L., et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004, 10(1):36-41.
44. Yao F.Y., Ferrell L., Bass N.M., et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001, 33(6):1394-1403.
45. Marsh J.W., Dvorchik I. Liver organ allocation for hepatocellular carcinoma: are we sure?. Liver Transpl 2003, 9(7):693-696.
46. Bruix J., Fuster J., Llovet J.M. Liver transplantation for hepatocellular carcinoma: foucault pendulum versus evidence-based decision. Liver Transpl 2003, 9(7):700-702.
47. Duffy J.P., Vardanian A., Benjamin E., et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 2007, 246(3):502-509.
48. Llovet J.M., Bruix J., Fuster J., et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 1998, 27(6):1572-1577.
49. Llovet J.M., Fuster J., Bruix J. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 2004, 10(2 Suppl 1):S115-S120.
50. Llovet J.M., Burroughs A., Bruix J. Hepatocellular carcinoma. Lancet 2003, 362(9399):1907-1917.
51. Yao F.Y., Bass N.M., Nikolai B., et al. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl 2003, 9(7):684-692.
52. Majno P.E., Sarasin F.P., Mentha G., et al. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 2000, 31(4):899-906.
53. Sala M., Fuster J., Llovet J.M., et al. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation. Liver Transpl 2004, 10(10):1294-1300.
54. Lau W.Y., Lai E.C. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 2009, 249(1):20-25.
55. Livraghi T., Goldberg S.N., Lazzaroni S., et al. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999, 210(3):655-661.
56. Sato S., Shiratori Y., Imamura M., et al. Power Doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: a prospective study using 199 consecutive patients. J Hepatol 2001, 35(2):225-234.
57. Castells A., Bruix J., Bru C., et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993, 18(5):1121-1126.
58. Arii S., Yamaoka Y., Futagawa S., et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000, 32(6):1224-1229.
59. Wood T.F., Rose D.M., Chung M., et al. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000, 7(8):593-600.
60. Llovet J.M., Vilana R., Bru C., et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001, 33(5):1124-1129.
61. Livraghi T., Solbiati L., Meloni M.F., et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003, 226(2):441-451.
62. Graziadei I.W., Sandmueller H., Waldenberger P., et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003, 9(6):557-563.
63. Llovet J.M., Mas X., Aponte J.J., et al. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut 2002, 50(1):123-128.
64. Majno P.E., Adam R., Bismuth H., et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997, 226(6):688-701.
65. Decaens T., Roudot-Thoraval F., Bresson-Hadni S., et al. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 2005, 11(7):767-775.
66. Porrett P.M., Peterman H., Rosen M., et al. Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl 2006, 12(4):665-673.
67. Yao F.Y., Kinkhabwala M., LaBerge J.M., et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant 2005, 5(4 Pt 1):795-804.
68. Bharat A., Brown D.B., Crippin J.S., et al. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve long-term survival. J Am Coll Surg 2006, 203(4):411-420.
69. Lewandowski R.J., Kulik L.M., Riaz A., et al. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 2009, 9(8):1920-1928.
70. Yao F.Y., Hirose R., LaBerge J.M., et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 2005, 11(12):1505-1514.